OAM
HRMY icon

OP Asset Management’s Harmony Biosciences HRMY Stock Holding History

OP Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,010
Closed -$248K – 802
2025
Q3 		$248K Sell
9,010
-2,506
-22% -$86.3K ﹤0.01% 724
2025
Q2 		$364K Buy
11,516
+11,172
+3,248% +$359K 0.01% 702
2025
Q1 		$11.4K Buy
+344
New +$12.3K ﹤0.01% 810

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OP Asset Management's HRMY Position: Q4 2025 in Review

OP Asset Management sold out of Harmony Biosciences (HRMY) in Q4 2025, closing a stake of 9,010 shares — an estimated $248K sold.

OP Asset Management first reported a position in HRMY in Q1 2025 and held it in 3 quarters. The position peaked at $364K in Q2 2025. 323 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • OP Asset Management reported no remaining Harmony Biosciences position as of Q4 2025 after selling out during the quarter.
  • OP Asset Management sold 9,010 Harmony Biosciences shares in Q4 2025, an estimated $248K.
  • OP Asset Management first reported a position in Harmony Biosciences in Q1 2025 and held it in 3 quarters.
  • OP Asset Management's Harmony Biosciences position peaked at $364K in Q2 2025.
  • 323 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on OP Asset Management's 13F filing for Q4 2025, filed 21 Apr 2026.